In Fiscal Year 2022, 1,357 competing RPGs were funded. 73% of competing dollars supported RFAs and grants within the established payline. RFA funds accounted for 12.5% of the FY 2022 competing dollars.
Number of RPG Awards
Download the Data
Includes Small Business Innovation Research and Small Business Technology Transfer Awards.
*Fiscal years 2017 through 2022 includes Cancer Moonshot funding appropriated that fiscal year and excludes all carryover obligations for fiscal years 2018 through 2022.
RPGs Summary, FY 2021-2022
Download the Data
RPG Awards Funded
(Dollars in Thousands)
| RPG Awards Funded |
2021 No. or % |
2021 Amount |
2022 No. or % |
2022 Amount |
|---|
| Total Funding for RPGs |
5,210 |
2,822,415 |
5,497 |
2,966,486 |
| SBIR/STTR |
238 |
158,269 |
207 |
151,396 |
| Funding for RPGs without SBIR/STTR Program |
4,972 |
2,664,145 |
5,290 |
2,815,090 |
| Continuation or Noncompeting Grants Funded |
3,641 |
1,886,072 |
3,933 |
2,013,233 |
| Competing Grants Funded |
1,331 |
640,878 |
1,357 |
665,061 |
| Administrative Supplements |
283 |
40,531 |
325 |
34,325 |
| Partial Assessment for DHHS Program Evaluation |
|
96,664 |
|
102,471 |
Funds Set Aside Within Competing Dollars
(Dollars in Thousands)
| Grant Category |
R01 or Share |
2021 No. or % |
2021 Amount |
2022 No. or % |
2022 Amount |
|---|
| Grants within Paylines |
|
1,007 |
440,021 |
992 |
430,938 |
| Traditional R01 |
733 |
376,081 |
710 |
371,261 |
| RFA Grants |
|
151 |
83,636 |
139 |
82,897 |
| Share of Competing Grant Funds |
13.1% |
|
12.5% |
|
| Exception Grants |
|
324 |
200,857 |
365 |
234,123 |
| Share of Competing Grant Funds |
31.3% |
|
35.2% |
|
Competing RPGs
| Statistical Measure |
2021 |
2022 |
|---|
| *Excludes SBIR/STTR |
| Traditional R01 includes R37 grants that have been converted to R01s. |
| 2022 figures include FY 2022 Cancer Moonshot funding and exclude all carryover obligations for fiscal years 2017 through 2021. |
| 2021 figures include FY 2021 Cancer Moonshot funding and exclude all carryover obligations for fiscal years 2017 through 2020. |
| Total Competing Application Requests* |
9,601 |
8,932 |
| Funding Success Rate |
14% |
15% |
| Percentile Funding for R01 Grants |
11th & 16th |
11th & 16th |
| Average Cost-Competing** |
$486 |
$490 |
| Average Reduction from Recommended/Requested Levels |
-14% |
-14% |
RPGs Funding Mechanisms
Download the Data
The "Other" category includes DP1, DP2, DP5, R00, R37, U01, U19,UH2, UH3, UG3, UA5, R50, UM1, R15, R55, R56 and R61 activities.
Grant Funding Paylines
| RPG Mechanism |
2021 |
2022 |
Description |
|---|
| *SPL = Scientific Program Leaders (NCI) |
| R01 Traditional Grants |
11th & 16th |
11th & 16th |
Percentile |
| P01 Program Projects |
17% Reduction |
17% Reduction |
SPL Selected* |
| R03 Small Grants |
25 |
25 |
Impact Score |
| R15 Academic Research |
25 |
25 |
Impact Score |
| R21 Exploratory Phase I |
9th |
9th |
Percentile |
| R33 Exploratory Phase II |
N/A |
N/A |
SPL Selected* |
| R41/R42 STTR |
28 |
24 |
Impact Score |
| R43/R44 SBIR |
22 |
24 |
Impact Score |
RPGs Requested and Awarded
The following table displays requested and awarded RPGs and the success rate for fiscal years 2021 and 2022. These numbers include Small Business Innovation Research (SBIR) and Small Business Technology Transfer (SBTT) awards. The Download the Data link contains data for the prior ten years.
Download the Data
RPGs Requested, Awarded, and Success Rate
(Dollars in Thousands)
| Fiscal Year |
Type |
Number Requested |
Amount Requested |
Number Awarded |
Amount Awarded |
Success Rate |
|---|
| Includes Small Business Innovation Research and Small Business Technology Transfer Awards. |
| Success rate is the number of awarded grants divided by the number of awards requested. |
| *Fiscal years 2017 through 2022 includes Cancer Moonshot funding appropriated that fiscal year and excludes all carryover obligations for fiscal years 2018 through 2022. |
2021
|
Competing New |
10,080 |
$4,935,665 |
1,336 |
$630,816 |
14.1%
|
| Competing Renewal |
409 |
289,208 |
141 |
93,308 |
| Competing Supplement |
39 |
16,065 |
9 |
2,875 |
| Competing Subtotal |
10,528 |
5,240,938 |
1,486 |
726,998 |
| Non- Competing |
|
|
3,724 |
2,095,416 |
| FY 2021 RPG Total |
|
|
5,210 |
$2,822,415 |
| 2022 |
Competing New |
9,580 |
$4,902,539 |
1,324 |
$635,623 |
14.8% |
| |
Competing Renewal |
431 |
335,464 |
154 |
107,730 |
| |
Competing Supplement |
28 |
8,867 |
12 |
3,363 |
| |
Competing Subtotal |
10,039 |
5,246,870 |
1,490 |
746,715 |
| |
Non- Competing |
|
|
4,007 |
2,219,770 |
| |
FY 2022 RPG Total |
|
|
5,497 |
$2,864,015 |
RPG Awards by Grant Activity Codes
This table displays awarded research project grants (RPG) data by grant activity code and count. Please visit NIH Activity Codes for more information on the descriptions.
Download the Data
RPGs Average Cost, FY 2012-2022
(Dollars in Thousands)
| Year |
Total No. Awarded |
Total Amount |
Average Cost |
|---|
| RPG Activity Codes with a "0" count displayed for No. are grants where NCI did not take the grant award count for the funding since NCI was not the Primary IC funding the award. |
| Starting in FY 2017, RFAs will be accounted for in the actual grant mechanism categories under which they fall. |
| *Fiscal years 2017 through 2022 includes Cancer Moonshot funding appropriated that fiscal year and excludes all carryover obligations for fiscal years 2018 through 2022. |
| **Fiscal year 2021 includes multi-year funded grants with a 1 year average cost estimation. |
| 2012 |
5,021 |
$2,075,295 |
$413 |
| 2013 |
4,816 |
$1,924,803 |
$400 |
| 2014 |
4,814 |
$1,939,623 |
$403 |
| 2015 |
4,767 |
$2,019,308 |
$424 |
| 2016 |
4,666 |
$2,068,869 |
$443 |
| *2017 |
4,663 |
$2,195,184 |
$471 |
| *2018 |
4,780 |
$2,366,530 |
$495 |
| *2019 |
4,984 |
$2,456,156 |
$493 |
| *2020 |
5,070 |
$2,677,206 |
$528 |
| **2021 |
5,221 |
$2,739,345 |
$525 |
| *2022 |
5,497 |
$2,864,015 |
$521 |
RPG Awards by Grant Activity Codes, FY 2021-2022
(Dollars in Thousands)
| Grant Code |
2021 Number |
2021 Amount |
2022 Number |
2022 Amount |
|---|
| RPG Activity Codes with a "0" count displayed for No. are grants where NCI did not take the grant award count for the funding since NCI was not the Primary IC funding the award. |
| From FY 2017 onward, RFAs will be accounted for in the actual grant mechanism categories under which they fall. |
| Fiscal years 2017 through 2021 includes Cancer Moonshot funding appropriated that fiscal year and excludes all carryover obligations for fiscal years 2018 through 2020. |
| Fiscal year 2021 includes multi-year funded grants with a 1 year average cost estimation. |
| R01 |
3,452 |
$1,625,672 |
3,584 |
$1,737,550 |
| DP1 |
0 |
0 |
0 |
0 |
| DP2 |
0 |
0 |
0 |
526 |
| DP5 |
0 |
0 |
0 |
0 |
| P01 |
97 |
198,889 |
98 |
200,007 |
| R00 |
78 |
18,841 |
93 |
22,788 |
| R37 |
220 |
100,632 |
277 |
128,583 |
| *RFA |
0 |
0 |
0 |
0 |
| U01 |
308 |
242,331 |
325 |
239,325 |
| U19 |
7 |
13,333 |
7 |
12,400 |
| UH2 |
7 |
1,603 |
10 |
2,117 |
| R35 |
166 |
158,472 |
152 |
146,781 |
| R50 |
77 |
12,889 |
72 |
12,716 |
| UH3 |
30 |
19,974 |
26 |
16,703 |
| UM1 |
15 |
55,880 |
14 |
52,568 |
| UG3 |
13 |
11,167 |
10 |
9.020 |
| R03 |
93 |
8,383 |
115 |
9,244 |
| R21 |
367 |
89,334 |
445 |
97,456 |
| R33 |
34 |
16,535 |
33 |
12,809 |
| R15 |
18 |
7,018 |
24 |
10,620 |
| R55 |
0 |
0 |
0 |
0 |
| R56 |
1 |
122 |
4 |
969 |
| R61 |
0 |
0 |
1 |
437 |
| RC2 |
0 |
0 |
0 |
0 |
| SBIR/STTR |
238 |
158,269 |
207 |
151,396 |
| Total |
5,221 |
$2,739,345 |
5,497 |
$2,864,015 |
